NeuroMetrix, Inc., a pioneering company in the field of neurotechnology, is headquartered in the United States and operates primarily across North America and Europe. Founded in 1996, NeuroMetrix has established itself as a leader in the development of innovative solutions for chronic pain management and diabetic neuropathy. The company’s flagship products, including the Quell® pain relief device and the DPNCheck® diagnostic tool, leverage advanced neurostimulation and diagnostic technologies, setting them apart in the healthcare landscape. NeuroMetrix is recognised for its commitment to improving patient outcomes through non-invasive therapies and has achieved significant milestones in clinical validation and market penetration. With a strong focus on research and development, NeuroMetrix continues to enhance its position in the neurotechnology industry, making strides in both product innovation and patient care.
How does NeuroMetrix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
NeuroMetrix, Inc.'s score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NeuroMetrix, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary of electroCore, Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from NeuroMetrix, it is important to note that the company may align its sustainability efforts with those of its parent organisation, electroCore, Inc. However, specific details regarding emissions reduction initiatives or targets have not been provided. As a subsidiary, NeuroMetrix may benefit from the broader climate strategies and commitments established by electroCore, Inc., but without explicit data or targets, the company's individual climate impact remains unclear.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
NeuroMetrix, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.